MBX Biosciences (MBX) News
NASDAQ: MBXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
49.55-3.86 (-7.23%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
MBX news summary
We found 3 recent headlines mentioning MBX Biosciences (MBX): 0 in the past week and 2 in the past 30 days, most often from GlobeNewswire, Seeking Alpha. MBX is making an outsized move today, down 7.23% at $49.55, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "MBX Biosciences GAAP EPS of -$1.29", was published by Seeking Alpha on Nov 9, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest MBX Biosciences headlines
- MBX Biosciences GAAP EPS of -$1.29Seeking Alpha
- MBX Biosciences Reports Third Quarter 2026 Financial Results and Corporate HighlightsEnrollment in pivotal Phase 3 oPTimize trial of once-weekly canvuparatide underwayGlobeNewswire
- MBX Biosciences to Participate in Upcoming November Investor ConferencesCARMEL, Ind. and BURLINGTON, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and…GlobeNewswire